Omnis Pharma's Merger

Omnis Pharma raised a round of funding on March 18, 2016. Investors include Vyriad.

Omnis Pharma is a clinical stage, biopharmaceutical company. The company is developing powerful Oncolytic virus therapies, utilizing engineered viruses designed to selectively and rapidly destroy canc…

Articles about Omnis Pharma's Merger: